T-group (topology)
2486.1.1 ClpP/crotonase
Ligands and drugs
7,931
Member domains
2,689
with ligand contacts (≤ 4 Å)
33.9% of members
1,917
with DrugDomain annotations
24.2% of members
1,101
with a DrugBank compound
13.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2486.1.1 belongs to X-group 2486 ClpP/crotonase, which binds 9.1 ligand superclasses per 20 proteins, broader than 82% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB07497 | BTI | 5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal | 114 |
| DB01992 | COA | Coenzyme A | 110 |
| DB03059 | CAA | Acetoacetyl-CoA | 34 |
| DB04519 | OCA | Caprylic acid | 28 |
| DB02563 | HXC | Hexanoyl-CoA | 19 |
| DB04045 | MCA | (R)-methylmalonyl-CoA | 18 |
| DB09140 | OXY | Oxygen | 17 |
| DB00149 | LEU | Leucine | 14 |
| DB02910 | CO8 | Octanoyl-Coenzyme A | 14 |
| DB03309 | NHE | N-cyclohexyltaurine | 14 |
| DB07571 | CMQ | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE | 14 |
| DB00121 | BTN | Biotin | 12 |
| DB02906 | CAX | (2s,4s)-Alpha-Campholinic Acid | 12 |
| DB04183 | DXX | Methylmalonic Acid | 12 |
| DB07870 | H1L | Haloxyfop-P | 11 |
| DB00188 | BO2 | Bortezomib | 7 |
| DB04117 | DAK | 4-(N,N-Dimethylamino)cinnamoyl-CoA | 7 |
| DB04491 | DFP | Diisopropylphosphono Group | 7 |
| DB00139 | SIN | Succinic acid | 6 |
| DB00173 | ADE | Adenine | 6 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BTI | 5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL | 190 |
| BTN | BIOTIN | 137 |
| BO2 | N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE | 133 |
| CL | CHLORIDE ION | 122 |
| COA | COENZYME A | 109 |
| MGmetal | MAGNESIUM ION | 104 |
| NAmetal | SODIUM ION | 80 |
| ACO | ACETYL COENZYME *A | 72 |
| VSZ | Cystargolide A (bound) | 70 |
| 1VU | propionyl Coenzyme A | 68 |
| CAmetal | CALCIUM ION | 65 |
| Kmetal | POTASSIUM ION | 64 |
| TW3 | ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{S},3~{S},4~{S},5~{S})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] 3-methylbut-2-enethioate | 60 |
| YE1 | [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL (3R)-4-({3-[(2-{[(3,5-DIHYDROXYPHENYL)ACETYL]AMINO}ETHYL)AMINO]-3-OXOPROPYL}AMINO)-3-HYDROXY-2,2-DIMETHYL-4-OXOBUTYL DIHYDROGEN DIPHOSPHATE | 42 |
| NImetal | NICKEL (II) ION | 35 |
| 1HA | 1-hydroxy-2-naphthoyl-CoA | 33 |
| CAA | ACETOACETYL-COENZYME A | 33 |
| ZNmetal | ZINC ION | 29 |
| 9DF | (6S,9aS)-6-[(2S)-butan-2-yl]-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-N-[4,4,4-tris(fluoranyl)butyl]-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide | 28 |
| AI4 | 4-[1-[3-[4-[(4-fluoranyl-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-quinazolin-7-yl]oxypropyl]piperidin-4-yl]benzamide | 28 |